Contact details

Andrew Edge

T: +44 20 7809 2102 M: +44 7771 921 780 Email Andrew | Vcard Office: London

Andrew Edge Partner

Contact details

Andrew Edge

Andrew Edge
Partner

T: +44 20 7809 2102 M: +44 7771 921 780 Email Andrew | Vcard Office: London

Andrew is head of the firm's corporate department and advises on public and private M&A, joint ventures and equity fundraisings.
  • Profile
  • Services
  • Sectors
  • Locations

He is ranked both as a leading M&A and life sciences lawyer by Chambers UK as well as being listed as one of The Lawyer magazine's "Hot 100" lawyers. He has also appeared in the Super Lawyers list of top lawyers since 2013.

Andrew advises corporate and financial clients on public and private M&A, joint ventures, IPOs and secondary fundraisings. With his previous law firm, Andrew spent three years as a partner in Frankfurt and has gained particular experience of Indian and Russian M&A, having acted on some of the largest multi-billion dollar transactions to have taken place in those jurisdictions.

"Incredibly pragmatic, a great sounding board and the ideal partner for our business"

 Chambers UK 2012

  • Public and private M&A
  • Projects and infrastructure
  • Joint ventures
  • Equity capital markets
  • Restructuring and insolvency

BTG plc

Advised BTG on its $475 million acquisition of PneumRx Inc and £160 million equity fundraising.

Advised BTG on its successful recommended bid for Biocompatibles International plc.

Acadia Healthcare

Advising this Tennessee headquartered behavioural health facilities provider on its $660 million acquisition of Partnerships in Care.


Baker Tilly (now re-named RSM)

Advising the UK's 9th largest accountancy practice on the acquisition of RSM Tenon, then the UK's 7th largest accountancy practice.


De Vere

Advised De Vere on the sale of The Grand Hotel, Brighton.


GDF SUEZ Energy Services/Cofely

Advised GDF on its £190 million acquisition of Balfour Beatty Workplace facilities management business.


Lavendon Group plc

Advised Lavendon on its successful defence against a hostile approach from TVH Servies NV and Ashtead Group plc.

More: Public and private M&A

Equitix

Advised Equitix on the acquisition of part of Laing O'Rourke's BSF portfolio.

Dutch Infrastructure Fund

Advised the fund on its acquisition of stakes in two Irish motorway PPP projects.

GDF Suez Energy Services/Cofely

Advised GDF on its acquisition of Balfour Beatty Workplace.

Cofely

Advised Cofely on its acquisition of Lend Lease Facilities Management Limited.

More: Projects and infrastructure

Kernal Holdings

Advised Kernal Holdings on its joint venture with Glencore International plc to acquire the Taman Port facilities on the Black Sea.

Tristan Capital

Advised client on its joint venture with Allianz to acquire the Warsaw Financial Centre.

JP Morgan

Advised JP Morgan on its joint venture with global shipping company, Bernhard Schulte, to acquire container ships.

More: Joint ventures

BTG

Advised BTG on its £160 million equity fundraising to fund the acquisition of PneumRX. 

Northland

Advised Northland on its role as Nomad to Evgen Pharmaceuticals on its AIM IPO.

Lavendon Group plc

Advised Lavendon on its £240 million placing and open offer and debt re-financing.

Oriel Securities

Advising Oriel Securities on its role as Nomad on the fundraising and re-admission to AIM of Rex Bionics.

More: Equity capital markets

Gentoo Group

Advised client on its acquisition of the assets of AIM listed Romag Holdings plc by way of pre-pack administration.

Baker Tilly

Advised Baker Tilly on its acquisition of RSM Tenon by way of pre-pack administration.

Pension Protection Fund

Advised client on the restructuring of Monarch Airlines.

Vanco plc

Represented Vanco on its sale by way of pre-pack administration.

More: Restructuring and insolvency
  • Life sciences

BTG plc

Advised on its $475 million acquisition of PneumRx Inc and £160 million equity fundraising.

Advised on its acquisition of EKOS Corporation Inc for $180 million.

Piramal Healthcare

Advised on the US$3.8 billion disposal of its Indian branded prescription generics business to Abbot.


Advised on its acquisition of US listed anaesthesia company Minrad International Inc.

Protherics plc

Advised on its acquisition by BTG plc to form the UK's largest listed biopharmaceutical company.

Commerzbank

Advised on the disposal of Kleinwort Benson to RHJ International in 2010.

More: Life sciences
  • UK
  • CIS and CEE
  • India

BTG plc

Advising on its successful recommended bid for Biocompatibles International plc.

Baker Tilly (now re-named RSM)

Advising the UK's 9th largest accountancy practice on the acquisition of RSM Tenon, then the UK's 7th largest accountancy practice.

De Vere

Advising on the sale of The Grand Hotel, Brighton.

GDF SUEZ Energy Services/Cofely

Advising on its £190 million acquisition of Balfour Beatty Workplace facilities management business.

Rusal Ltd

Advising on its US$30 billion merger with SUAL and the alumina assets of Glencore International to form United Company Rusal Ltd.

United Company Rusal Ltd

Advising this company and its majority shareholder (EN+Group Ltd) on the US$14 billion acquisition of a 25% stake in Russian copper and nickel miner Norilsk Nickel.

STADA Arzneimittel

Advised on its acquisition of Russian generics pharmaceutical company Nizhpharm.

United Company Rusal Limited

Advised on the shareholder arrangements concerning its Hong Kong IPO.

More: CIS and CEE

Piramal Enterprises

Advised on the US$3.8 billion disposal of its Indian branded prescription generics business to Abbot.


Advised on its acquisition of US listed anaesthesia company Minrad International Inc.

Advised on the acquisition of a pharmaceuticals manufacturing site from Pfizer.

More: India

Latest news & insights

05 Dec 2017

From News

Stephenson Harwood advises TyraTech on aspects of Vamousse sale to Alliance Pharma and tender offer to shareholders

Law firm Stephenson Harwood LLP has advised a new client, AIM-listed life sciences company TyraTech Inc. on the shareholder consent required for the US$17.5 million sa..

More

19 Oct 2017

From News

Stephenson Harwood advises Novacyt SA on AIM IPO

Law firm Stephenson Harwood LLP has advised Novacyt SA on its €25 million AIM IPO.

More

20 Jun 2017

From News

Stephenson Harwood advises Shield Therapeutics plc on £12 million fundraising

Law firm Stephenson Harwood LLP has advised Shield Therapeutics plc on its £12 million fundraise by way of a co-ordinated exercise of existing warrants, subscription o..

More

08 May 2017

From News

Stephenson Harwood advises on acquisition of Lavendon by Loxam

Law firm Stephenson Harwood LLP has advised European powered access market leader Lavendon Group PLC on its contested takeover by French group Loxam.

More

02 Mar 2017

From News

Stephenson Harwood advises ENGIE on Keepmoat acquisition

Law firm Stephenson Harwood LLP has advised energy and services provider ENGIE on the £330 million acquisition of regeneration business Keepmoat from TDR and Sun Capit..

More

30 Nov 2016

From News

Stephenson Harwood wins leading healthcare award

Stephenson Harwood has been named 'Legal Advisor of the Year' in the Independent category at the LaingBuisson Healthcare Awards 2016.

More

11 Oct 2016

From News

Stephenson Harwood advises Tractebel on acquisition of majority stake in RED Engineering

Law firm Stephenson Harwood LLP has advised Tractebel on its acquisition of a 70 percent stake in RED Engineering, a company which designs mechanical, electrical and p..

More

26 Jul 2016

From News

Stephenson Harwood advises Inflection Management Corporation on recommended offer for Superglass Holdings Plc

Law firm Stephenson Harwood LLP has advised Inflection Management Corporation on its £13.2 million recommended public takeover and refinancing of Superglass Holdings P..

More

10 May 2016

From News

Stephenson Harwood advises BTG on US$110 million interventional medicine acquisition

International law firm Stephenson Harwood LLP has advised healthcare company BTG PLC on its acquisition of Galil Medical, a US-based kidney cancer treatment company, i..

More

25 Feb 2016

From News

Stephenson Harwood advises on £162 million IPO for Shield Therapeutics plc

Stephenson Harwood LLP has advised Shield Therapeutics plc (“Shield”) on its £162 million AIM IPO.

More

04 Jan 2016

From News

Stephenson Harwood advises Acadia on acquisition of Priory Group

Stephenson Harwood has advised Acadia Healthcare on the acquisition of Priory Group, a leading provider of behavioural healthcare facilities in the United Kingdom.

More

10 Dec 2014

From News

Stephenson Harwood advises on BTG’s up to $475 million acquisition of Pneumrx

Stephenson Harwood LLP advised BTG Plc on acquisition of PneumRx Inc for an initial cash consideration of $230m and up to $245m in performance-related milestone payme..

More

26 Oct 2014

From News

Stephenson Harwood LLP advises on restructuring of Monarch Airlines

Stephenson Harwood LLP played a pivotal role in the restructuring of Monarch Airlines which completed on Friday night (24 October 2014).

More

13 Jul 2014

From News

Stephenson Harwood advises Cofely on the purchase of LLFM

Stephenson Harwood LLP advised Cofely, a wholly owned subsidiary of GDF SUEZ, on its purchase of Lend Lease’s UK facilities management business.

More

30 Jun 2014

From News

Stephenson Harwood advises Acadia Healthcare on $662 million acquisition

Stephenson Harwood LLP advised Acadia Healthcare Company on a US$662 million agreement to acquire Partnerships in Care (PiC).

More

05 May 2014

From News

Stephenson Harwood advises Baker Tilly on sale of business

Stephenson Harwood LLP advised Baker Tilly, UK's seventh-biggest auditing and accounting advisory firm, on the sale of its private client financial management busines..

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.